$4.14 -0.03 (-0.72%)
11/6/2009 4:02 PM

AMERICAN ORIENTL BIO (AOB)

CAPS Rating: 5 out of 5

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

Current Price $4.14 Mkt Cap $328.31M
Open $4.16 P/E Ratio 6.95
Prev. Close $4.17 Div. (Yield) N/A (N/A)
Daily Range $4.01 - $4.20 Volume 872,950
52-Wk Range $3.29 - $7.66 Avg. Daily Vol. 1,101,000

AOB News and Commentary

View All AOB News and Commentary

Caps

How do you think AOB will perform vs the S&P 500?

Add Stock to Watchlist

All Members

3,054 Outperform
84 Underperform
 

All-Star Members

922 Outperform
27 Underperform
 

Wall Street

3 Outperform
1 Underperform
 

Top AOB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mrindependent (98.79)
Submitted October 01, 2009

According to Jubak, the Chinese government is making a substantial push to expand the country's healthcare sector. American Oriental Biology ought to benefit from this initiative. The price is right at 1.04 times book value and 6 times estimated… More

xserver (98.95)
Submitted September 25, 2009

Will they be delisted from the NYSE? Maybe I should buy puts in real life?

AOB VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about AOB.

Recs

0
Member Avatar wkentward (< 20) Submitted: 10/30/2009 5:22:46 PM : Outperform Start Price: $3.97 AOB Score: +0.97

Exceptional fundamentals and revenue growth

Recs

1
Member Avatar brianpivar (94.60) Submitted: 10/30/2009 5:30:21 AM : Outperform Start Price: $5.16 AOB Score: -29.01

This companies EPS for the year is predicted to be .62 which makes the P/E for this year 4.24/.62 = 6.8.
Next years EPS is predicted to be .77 which would make its forward p/e 5.5
The industry average for p/e in this sector is 14.3

Best way to play this stock....
I am looking at the Jan 2011 $5 call options for roughly 1.1.

However this isn't a bad stock to buy right around $4.

Recs

1
Member Avatar Streetlife373 (< 20) Submitted: 10/24/2009 1:44:37 AM : Outperform Start Price: $4.45 AOB Score: -5.98

Global Gains just downgraded AOB to Sell. I usually agree on the teams recommendations, but in this case, they are so so wrong.

AOB is a certain winner. It has all the fundamentals of a very sound company and their recent earnings report was quite positive as well. When this whole wave of bad press blows over, AOB is going to start it's march up to the double digits.

I'm still LONG on AOB. Great growth prospects here

Leaderboard

Find the members with the highest scoring picks in AOB.

Score Leader

EPS100Momentum

EPS100Momentum (69.62) Score: +138.72

Do you want more picks like this one? Follow my blog EPS100Momentum EPS100Momentum says: To make big money in the market is to identify your losers quickly and to let your winners run. Also u must be able to identify the sector thats growing the fastest. Mistake is to be in bad sector.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
omt68 80.17 12/31/2008 Underperform 1Y $6.30 -34.29% +22.39% +56.68 1 Comment
airplane44 76.11 11/21/2008 Underperform 3Y $4.70 -11.91% +42.52% +54.43
diditbad100 72.13 3/9/2009 Underperform 5Y $3.88 +6.70% +60.39% +53.69 2 Comments
statsguy 90.31 12/5/2008 Underperform 3Y $5.28 -21.52% +31.95% +53.47 1 Comment
peterlista 67.05 11/21/2008 Underperform 3W $4.47 -7.38% +42.46% +49.84
rku758 54.70 12/14/2006 Underperform 1Y $12.71 -67.43% -19.84% +47.58
stoneyg72 98.69 2/9/2009 Underperform 3W $5.31 -22.03% +25.37% +47.40
nilro 80.40 1/28/2009 Underperform 5Y $5.34 -22.44% +24.82% +47.26
dadosweeny 46.92 11/5/2008 Underperform NS $6.50 -36.31% +10.77% +47.08
dangerfairy 98.13 11/5/2008 Underperform NS $6.50 -36.31% +10.77% +47.08

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackMerriman < 20 1/12/2009 Outperform NS $5.29 -21.74% +22.72% -44.46
TrackPiperJaff 80.38 1/8/2009 Underperform NS $6.25 -39.52% -21.97% +17.55 3/10/2009 @ $3.78
TrackRothCapital 75.81 12/30/2008 Outperform NS $6.34 -34.70% +24.15% -58.85
TrackZacks 69.52 11/11/2008 Outperform 3M $6.25 -31.36% -1.18% -30.18 5/15/2009 @ $4.29 1 Comment
TrackJefferies 75.83 11/21/2007 Outperform NS $10.65 -61.13% -21.55% -39.57
TrackZacks 69.52 10/22/2007 Outperform 3M $12.53 -54.51% -34.36% -20.15 10/20/2008 @ $5.70 1 Comment
TrackWIG 91.78 10/1/2007 Outperform 1Y $11.23 +24.31% +1.00% +23.31 10/31/2007 @ $13.96
TrackLazardCapit < 20 7/9/2007 Outperform NS $9.70 -28.87% -18.56% -10.31 9/23/2008 @ $6.90
TrackPiperJaff 80.38 7/9/2007 Outperform NS $9.66 -34.78% -38.99% +4.20 1/8/2009 @ $6.30
TrackBreanMurray 89.84 10/30/2006 Outperform NS $7.04 -36.08% -37.44% +1.36 4/27/2009 @ $4.50
TrackJimCramer < 20 6/6/2006 Underperform 3W $5.52 -25.00% -9.73% +15.27

Featured Broker Partners